Clinical Trial Update: Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on a Vitamin D and K2 combination with empagliflozin for diabetes mellitus is noted with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Vitamin D (Cholecalciferol)
• Vitamin K2 (menaquinone)

Snippet

Sponsor: Scotmann Pharmaceuticals | Conditions: Diabetes Mellitus | Phase 3 | Status: UNKNOWN